Loncar Cancer Immunotherapy Etf Technical Analysis
| CNCR Etf | USD 13.56 0.34 2.57% |
As of the 25th of November, Loncar Cancer secures the Mean Deviation of 1.64, standard deviation of 2.14, and Risk Adjusted Performance of (0.03). Loncar Cancer Immunotherapy technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the etf's future prices. Please verify Loncar Cancer Immuno variance and potential upside to decide if Loncar Cancer Immunotherapy is priced some-what accurately, providing market reflects its recent price of 13.56 per share.
Loncar Cancer Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Loncar, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to LoncarLoncar |
Loncar Cancer technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Loncar Cancer Immuno Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Loncar Cancer Immuno volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Loncar Cancer Immuno Trend Analysis
Use this graph to draw trend lines for Loncar Cancer Immunotherapy. You can use it to identify possible trend reversals for Loncar Cancer as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Loncar Cancer price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Loncar Cancer Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Loncar Cancer Immunotherapy applied against its price change over selected period. The best fit line has a slop of 0.02 , which may suggest that Loncar Cancer Immunotherapy market price will keep on failing further. It has 122 observation points and a regression sum of squares at 9.46, which is the sum of squared deviations for the predicted Loncar Cancer price change compared to its average price change.About Loncar Cancer Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Loncar Cancer Immunotherapy on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Loncar Cancer Immunotherapy based on its technical analysis. In general, a bottom-up approach, as applied to this etf, focuses on Loncar Cancer Immuno price pattern first instead of the macroeconomic environment surrounding Loncar Cancer Immuno. By analyzing Loncar Cancer's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Loncar Cancer's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Loncar Cancer specific price patterns or momentum indicators. Please read more on our technical analysis page.
Loncar Cancer November 25, 2024 Technical Indicators
Most technical analysis of Loncar help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Loncar from various momentum indicators to cycle indicators. When you analyze Loncar charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.06) | |||
| Mean Deviation | 1.64 | |||
| Coefficient Of Variation | (1,986) | |||
| Standard Deviation | 2.14 | |||
| Variance | 4.59 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (0.46) | |||
| Treynor Ratio | (0.07) | |||
| Maximum Drawdown | 11.54 | |||
| Value At Risk | (3.72) | |||
| Potential Upside | 4.08 | |||
| Skewness | 0.0837 | |||
| Kurtosis | 0.5311 |
Loncar Cancer Immuno One Year Return
Based on the recorded statements, Loncar Cancer Immunotherapy has an One Year Return of 29.2%. This is 233.76% lower than that of the Loncar Investments family and 233.76% lower than that of the Health category. The one year return for all United States etfs is notably lower than that of the firm.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Loncar Cancer Immunotherapy. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
The market value of Loncar Cancer Immuno is measured differently than its book value, which is the value of Loncar that is recorded on the company's balance sheet. Investors also form their own opinion of Loncar Cancer's value that differs from its market value or its book value, called intrinsic value, which is Loncar Cancer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Loncar Cancer's market value can be influenced by many factors that don't directly affect Loncar Cancer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Loncar Cancer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Loncar Cancer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Loncar Cancer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.